Drug
Lnp3794
Lnp3794: highest development phase Phase 1, developed by Lupin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| LNP3794 NCT05187858 | Phase 1 | NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors |
Latest
No recent events.
Follow Lnp3794 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.